OnCo

Create your OnCo account

One account keeps your watchlist, saved views and cancer choice in sync across your devices, and lets OnCo alert you when a trial or treatment you follow changes. No password: we email you a sign-in link.

Account creation is being switched on. Until then, press Watch on any page and your list stays in this browser.

Central nervous system germ cell tumours (germinoma and non-germinomatous): lines of therapy

Cancer page →

5 standard-of-care settings across 4 lines and 1 biomarker subgroup. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.

LineAll comers
Early / localised1
Advanced, first line1
Second line1
Other settings2

Early / localised

SubgroupSettingApproachProducts and trialsEvidence
All comersLocalised germinomaPlatinum-based chemotherapy (carboplatin and etoposide, with ifosfamide in the SIOP schedule) followed by reduced-dose whole-ventricular irradiation with a tumour boost (SIOP CNS GCT II, ACNS1123); craniospinal irradiation alone remains an alternative in adults.93

Advanced, first line

SubgroupSettingApproachProducts and trialsEvidence
All comersDisseminated germinomaCraniospinal irradiation with boosts, with or without chemotherapy.93

Second line

SubgroupSettingApproachProducts and trialsEvidence
All comersRelapseHigh-dose chemotherapy (thiotepa-based) with autologous stem cell rescue, with re-irradiation where possible.87

Other settings

SubgroupSettingApproachProducts and trialsEvidence
All comersNon-germinomatous germ cell tumourIntensive cisplatin or carboplatin, etoposide and ifosfamide chemotherapy, second-look surgery for residual disease, then craniospinal or whole-ventricular irradiation depending on stage and response (ACNS0122, ACNS1123, SIOP CNS GCT II).93
All comersTeratomaComplete surgical resection; growing teratoma after chemotherapy is also managed surgically.40

Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.